166 related articles for article (PubMed ID: 21478824)
1. Expression of FOXL2 in human normal pituitaries and pituitary adenomas.
Egashira N; Takekoshi S; Takei M; Teramoto A; Osamura RY
Mod Pathol; 2011 Jun; 24(6):765-73. PubMed ID: 21478824
[TBL] [Abstract][Full Text] [Related]
2. Expression of pituitary homeo box 1 (Ptx1) in human non-neoplastic pituitaries and pituitary adenomas.
Tahara S; Kurotani R; Sanno N; Takumi I; Yoshimura S; Osamura RY; Teramoto A
Mod Pathol; 2000 Oct; 13(10):1097-108. PubMed ID: 11048804
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
[TBL] [Abstract][Full Text] [Related]
4. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
Oyama K; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of retinoid X receptor isoforms in human pituitaries and pituitary adenomas.
Sanno N; Sugawara A; Teramoto A; Abe Y; Yen PM; Chin WW; Osamura RY
Neuroendocrinology; 1997 Apr; 65(4):299-306. PubMed ID: 9143002
[TBL] [Abstract][Full Text] [Related]
6. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
[TBL] [Abstract][Full Text] [Related]
7. Impaired FSHbeta expression in the pituitaries of Foxl2 mutant animals.
Justice NJ; Blount AL; Pelosi E; Schlessinger D; Vale W; Bilezikjian LM
Mol Endocrinol; 2011 Aug; 25(8):1404-15. PubMed ID: 21700720
[TBL] [Abstract][Full Text] [Related]
8. Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway.
Miyakoshi T; Takei M; Kajiya H; Egashira N; Takekoshi S; Teramoto A; Osamura RY
Endocr Pathol; 2008; 19(4):261-73. PubMed ID: 19034702
[TBL] [Abstract][Full Text] [Related]
9. Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas.
Kurotani R; Yasuda M; Oyama K; Egashira N; Sugaya M; Teramoto A; Osamura RY
Mod Pathol; 2001 Aug; 14(8):791-7. PubMed ID: 11504839
[TBL] [Abstract][Full Text] [Related]
10. Leptin and the pituitary.
Sone M; Osamura RY
Pituitary; 2001; 4(1-2):15-23. PubMed ID: 11824504
[TBL] [Abstract][Full Text] [Related]
11. Significance of growth hormone-releasing hormone receptor mRNA in non-neoplastic pituitary and pituitary adenomas: a study by RT-PCR and in situ hybridization.
Oka H; Kameya T; Sato Y; Naritaka H; Kawano N
J Neurooncol; 1999 Feb; 41(3):197-204. PubMed ID: 10359139
[TBL] [Abstract][Full Text] [Related]
12. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of human natural killer cell like immunoreactivity in human pituitary adenomas, using monoclonal antibody NK-1.
Sanno N; Itoh J; Teramoto A; Itoh Y; Hori S; Osamura RY
J Neurooncol; 1997 Oct; 35(1):29-38. PubMed ID: 9266438
[TBL] [Abstract][Full Text] [Related]
14. Expression of MSX1 in human normal pituitaries and pituitary adenomas.
Mizokami Y; Egashira N; Takekoshi S; Itoh J; Itoh Y; Osamura RY; Matsumae M
Endocr Pathol; 2008; 19(1):54-61. PubMed ID: 18379900
[TBL] [Abstract][Full Text] [Related]
15. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas.
Kim K; Arai K; Sanno N; Osamura RY; Teramoto A; Shibasaki T
Clin Endocrinol (Oxf); 2001 Jun; 54(6):759-68. PubMed ID: 11422110
[TBL] [Abstract][Full Text] [Related]
17. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
Buurman H; Saeger W
Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical studies on human pituitary gland and adenomas.
Kasper M; Kasper M; Kern F; Heitz PU; Gudat F
J Hirnforsch; 1991; 32(6):725-34. PubMed ID: 1821419
[TBL] [Abstract][Full Text] [Related]
19. Immunonegative "null cell" adenomas and gonadotropin (Gn) subunit (SUs) immunopositive adenomas share frequent expression of multiple transcription factors.
Ishii Y; Suzuki M; Takekoshi S; Egashira N; Yamazaki M; Miyai S; Sanno N; Teramoto A; Osamura RY
Endocr Pathol; 2006; 17(1):35-43. PubMed ID: 16760578
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas.
Jameson JL; Klibanski A; Black PM; Zervas NT; Lindell CM; Hsu DW; Ridgway EC; Habener JF
J Clin Invest; 1987 Nov; 80(5):1472-8. PubMed ID: 2824561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
